Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
232studies shown
Showing 126-150 of 232
RecruitingNCT04972136

rTMS for Depression in Young Adults With Autism

This study is comparing Active Bilateral Theta Burst Stimulation with Sham bilateral theta burst stimulation for people with Autism Spectrum Disorder or depression. Participants receive Active Bilateral Theta Burst Stimulation or Sham bilateral theta burst stimulation and complete study visits and assessments.

DepressionOtherFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
RecruitingNCT07140575

rTMS for Youth Inpatients With Depression

This study is looking at whether repetitive transcranial magnetic stimulation (rTMS) can help people with Major moderate depression or Feasibility Studies. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDeviceFrom 14 Years to 19 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Depression
RecruitingNCT06929533

Pharmacogenomics-Supported Psychotropic Prescribing Trial

This study is looking at whether questionnaires and follow-up can help people with Mental Disorder, Pharmacogenetics, Adverse Drug Reaction, or Effectiveness. Participants receive a study treatment and complete follow-up visits and assessments.

Mental healthOtherOver 18 Years
Countries
Canada
Sponsor
University of Manitoba
Condition
Mental health
RecruitingNCT04797364

Pharmacogenetic Supported Prescribing in Kids

This study is looking at whether a digital support tool can help people with Mental Health Impairment. Participants receive a study treatment and complete follow-up visits and assessments.

Mental healthOtherFrom 6 Years to 24 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Mental health
RecruitingNCT06032377

Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints

This study is looking at whether cognitive behavioural therapy can help people with Insomnia. Participants take part in the program and complete follow-up questionnaires or assessments.

Mental healthOtherFrom 60 Years to 99 Years
Countries
Canada
Sponsor
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Condition
Mental health
RecruitingNCT07413705

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

This study is looking at whether a digital support tool can help people with Depressive Symptoms, Urinary Incontinence, or Sexual Dysfunction. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionOtherOver 40 Years
Countries
Canada, United States
Sponsor
BTL Industries Ltd.
Condition
Depression
RecruitingNCT06299319

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD

This study is looking at evaluate the safety, feasibility, and clinical effects of psilocybin administration in those with OCD for people with Obsessive-Compulsive Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

Mental healthOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Mental health
RecruitingNCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 5 Years to 17 Years
Countries
Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05142735

Effects of NAC on Symptoms of CHR Patients

This study is comparing N-Acetylcysteine with placebo for people with Prodromal Schizophrenia. Participants receive N-Acetylcysteine or placebo and complete study visits and assessments.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07428460

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia and Predominant Negative Symptoms. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
RecruitingNCT06672588

Magnetic Seizure Therapy for Schizophrenia - Trial

This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07383324

Heat Stress in Individuals With Schizophrenia

This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Schizophrenia
RecruitingNCT05435300

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

This study is looking at examine changes in synaptic density with transcranial direct current stimulation (tDCS) in the brains of patients with schizophrenia for people with Schizophrenia or Schizoaffective. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT05731414

Outcomes From Remediation and Behavioural Intervention Techniques

This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
RecruitingNCT07056894

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT07001878

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 25 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT06126224

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Belgium, Canada, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Switzerland, Turkey, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT06373484

Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents

This study is looking at whether cognitive behavioural therapy can help people with Disruptive Behavior Disorder, Emotional Disorder, Behavioural Disorder, or Attention Deficit Hyperactivity Disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
ADHD